Chang Yaramothu

Title: Chang Yaramothu: Innovator in Binocular Dysfunction Assessment and Treatment

Introduction

Chang Yaramothu is a notable inventor based in Hackensack, NJ (US). He has made significant contributions to the field of vision therapy, particularly in the assessment and treatment of binocular dysfunctions. With a total of 2 patents, Yaramothu's work is paving the way for advancements in visual health.

Latest Patents

Yaramothu's latest patents include a "Method, system and apparatus for diagnostic assessment and screening of binocular dysfunctions." This invention relates to systems, methods, and apparatus designed to objectively assess binocular dysfunction for screening, diagnoses, and evaluation of vision and oculomotor function. The systems and methods can automatically diagnose and assess binocular dysfunction, rendering visual stimuli on one or more displays while controlling accommodative and proximal vergence stimulation of a user's eyes.

Another significant patent is the "Method, system, and apparatus for treatment of binocular dysfunctions." This invention focuses on vision therapy, where a visual therapy game can be rendered on one or more displays. The game is controlled by the user's eye movements, incorporating visual stimuli to facilitate vergence eye movements for the treatment of binocular dysfunctions.

Career Highlights

Chang Yaramothu is affiliated with the New Jersey Institute of Technology, where he continues to innovate in the field of vision therapy. His work is characterized by a commitment to improving diagnostic and therapeutic methods for binocular dysfunctions.

Collaborations

Yaramothu collaborates with esteemed colleagues, including Tara Lynn Alvarez and John Vito D'Antonio-Bertagnolli. Their combined expertise enhances the research and development of effective solutions for vision-related challenges.

Conclusion

Chang Yaramothu's contributions to the field of binocular dysfunction assessment and treatment are noteworthy. His innovative patents reflect a dedication to advancing visual health and improving therapeutic interventions.